PGNY Progyny

Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Michael Sturmer, Progyny’s President, will participate in a fireside chat at Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024 at 10:15 A.M. Eastern Time.

A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at

About Progyny

Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients and physicians. 

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs. 

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes’ Best Employers, Financial Times, Inc. 5000, Inc. Power Partners, and Crain’s Fast 50 for NYC. For more information, visit .

For Further Information, Please Contact:

Investors:

James Hart

Media:

Selena Yang



EN
11/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progyny

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

 PRESS RELEASE

Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference...

Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024 NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Progyny’s executives will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Wednesday, May 15, 2024, at 5:00 P.M. Pacific Time / 8:00 P.M. Eastern Time. They will also participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conferenc...

 PRESS RELEASE

Progyny, Inc. Announces First Quarter 2024 Results

Progyny, Inc. Announces First Quarter 2024 Results Early Sales Activity and New Partnerships Provide Strong Start to Selling Season, Affirming Continued Demand for Fertility and Family Building Solutions NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the three-month period ended March 31, 2024 (“the first quarter of 2024”) as compared to the three-month period ended March 31, 2023 (“the first quarter of 2023” o...

 PRESS RELEASE

Progyny, Inc. Announces Details for Its First Quarter 2024 Results Rep...

Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period ended March 31, 2024 after the close of the market on Thursday, May 9, 2024. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States...

 PRESS RELEASE

Progyny and Fertility Matters Canada Recognize Canadian Fertility Awar...

Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care The organizations will host an event with Canada’s leading providers, employers, and fertility advocates to show support for the millions in need of family building care NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and , a national fertility patient-focused organization, today announced both organizations will be co-hosting an event to garner support for...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch